NCT02262663View on ClinicalTrials.gov

Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Clinical Trial, Phase I
Interventions
DRUG

Vilaprisan (BAY1002670)

Trial Locations (2)

10115

Berlin

13353

Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY